Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
23%
OVERLAP
BY WEIGHT
24
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
50%
ALSO IN BBP
BBP
57
HOLDINGS
39%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.5% | 2.1% | 2.1% |
|
UNITED THERAPEUTICS CORP | 3.4% | 1.8% | 1.8% |
|
PTC THERAPEUTICS INC | 1.8% | 2.0% | 1.8% |
|
AMGEN INC | 3.7% | 1.7% | 1.7% |
|
INCYTE CORP | 1.6% | 2.0% | 1.6% |
FTXH Overweight Relative to BBP
|
MERCK & CO. INC. | 7.3% |
|
JOHNSON & JOHNSON | 7.3% |
|
ABBVIE INC | 7.1% |
|
PFIZER INC | 6.4% |
|
BRISTOL-MYERS SQUIBB CO | 6.2% |
|
ELI LILLY & CO | 4.6% |
|
CARDINAL HEALTH INC | 4.5% |
|
VIATRIS, INC. | 3.1% |
|
REGENERON PHARMACEUTICALS | 2.8% |
 |
JAZZ PHARMACEUTICALS PLC | 2.6% |
FTXH Underweight Relative to BBP
|
BEIGENE LTD. SPONSORED ADR | -2.9% |
|
INSMED INC | -2.7% |
|
BRIDGEBIO PHARMA, INC. | -2.6% |
|
ALNYLAM PHARMACEUTICALS INC | -2.6% |
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
RHYTHM PHARMACEUTICALS, INC. | -2.6% |
|
ASCENDIS PHARMA A/S | -2.6% |
|
MIRUM PHARMACEUTICALS, INC. | -2.5% |
|
PHATHOM PHARMACEUTICALS, INC. | -2.5% |
|
SAGE THERAPEUTICS INC | -2.5% |